On September 20, Simcere Pharma (02096) spent 3.7869 million Hong Kong dollars to repurchase 610,000 shares.
Sinopharm Group Co., Ltd. (02096) announced that the company invested 3.7869 million Hong Kong dollars on September 20, 2024...
SIMCERE PHARMA (02096) announced that the company repurchased 610,000 shares for a total of HK$3.769 million on September 20, 2024, at a repurchase price range of HK$6.17 to HK$6.25 per share.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
